Tracking down the origin of leukemia relapse

Apr 04, 2011

The cancer cells that reign during relapses of an aggressive human leukemia are different from those that dominated the original disease, according to a paper published online on April 4 in the Journal of Experimental Medicine.

By comparing the DNA of cancer cells taken at the time of diagnosis and relapse from patients with T cell acute lymphoblastic (T-ALL), Jean Soulier and co-workers found that the relapse cells arose from cells that were scarce at the time of diagnosis. The relapse cells had also picked up several new and dangerous mutations. Mimicking these mutations in cells isolated at diagnosis rendered them more cancerous after injection into immune-depleted mice.

Untouched cancer cells from diagnosis samples also caused leukemia when injected into mice. And once established, they bore a closer genetic resemblance to relapse cells than to their former selves, suggesting that the most aggressive prevail in both mouse and man.

These findings suggest that tracking human leukemia development in immune-depleted mice might provide insight into the mechanisms underlying relapses of the human disease.

Explore further: New cancer drug target involving lipid chemical messengers

More information: Clappier, E., et al. 2011. J. Exp. Med. doi:10.1084/jem.20110105

add to favorites email to friend print save as pdf

Related Stories

Targeting cell pathway may prevent relapse of leukemia

Mar 25, 2010

About 40 percent of children and up to 70 percent of adults in remission from acute myelogenous leukemia (AML) will have a relapse. In recent years, doctors have come to believe that this is due to leukemia stem cells, endlessly ...

Molecular change may reveal risk of leukemia relapse

Apr 30, 2008

Researchers may have discovered a better way to distinguish acute leukemia patients who require aggressive treatment to prevent recurrence from those who need only standard therapy for cure. The study is published in the ...

Recommended for you

User comments : 0